Axcan, Scandipharm Inc., Trilobite Lakes Corp. deal

Trilobite increased by $2 a share to $8 its bid to acquire Scandipharm, a distributor of gastrointestinal, nutritional and cystic fibrosis products, matching the offer made by AXP earlier this month (...